ERECTILE DYSFUNCTION TREATMENT MARKET ANALYSIS

Regional Analysis

Global Erectile Dysfunction Treatment Market - Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global erectile dysfunction treatment market over the forecast period. North America is estimated to hold 33.9% of the market share in 2023 owing to key players operating in the market focusing on product launches. For instance, in June 2023, Futura Medical, a research and development pharmaceutical company, had developed Eroxon, a topical gel for erectile dysfunction, which has been authorized for over-the-counter marketing in the U.S.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa